Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| kidney loop of Henle epithelial cell | 5 studies | 42% ± 20% | |
| pericyte | 4 studies | 31% ± 7% | |
| epithelial cell | 3 studies | 36% ± 18% | |
| retinal pigment epithelial cell | 3 studies | 20% ± 5% | |
| epithelial cell of proximal tubule | 3 studies | 44% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| kidney | 4 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 2321.37 | 89 / 89 | 90% | 56.39 | 810 / 901 |
| thymus | 97% | 995.65 | 632 / 653 | 57% | 4.64 | 345 / 605 |
| pancreas | 100% | 3312.36 | 328 / 328 | 45% | 4.25 | 80 / 178 |
| lung | 91% | 627.39 | 526 / 578 | 13% | 1.21 | 151 / 1155 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.63 | 1 / 1 |
| heart | 100% | 730.31 | 857 / 861 | 0% | 0 | 0 / 0 |
| breast | 91% | 495.90 | 417 / 459 | 6% | 0.33 | 62 / 1118 |
| muscle | 86% | 205.40 | 691 / 803 | 0% | 0 | 0 / 0 |
| adipose | 77% | 338.35 | 932 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 64% | 283.19 | 115 / 180 | 5% | 0.41 | 23 / 430 |
| uterus | 53% | 140.22 | 90 / 170 | 9% | 1.01 | 41 / 459 |
| adrenal gland | 26% | 67.89 | 68 / 258 | 35% | 4.27 | 80 / 230 |
| esophagus | 54% | 169.88 | 787 / 1445 | 2% | 0.06 | 3 / 183 |
| stomach | 54% | 181.86 | 193 / 359 | 2% | 0.43 | 5 / 286 |
| prostate | 53% | 143.77 | 129 / 245 | 1% | 0.06 | 6 / 502 |
| bladder | 48% | 77.43 | 10 / 21 | 5% | 0.38 | 23 / 504 |
| intestine | 49% | 117.94 | 474 / 966 | 2% | 0.21 | 9 / 527 |
| blood vessel | 48% | 146.89 | 642 / 1335 | 0% | 0 | 0 / 0 |
| skin | 43% | 124.02 | 782 / 1809 | 1% | 0.14 | 6 / 472 |
| liver | 13% | 31.52 | 29 / 226 | 26% | 2.24 | 105 / 406 |
| brain | 7% | 18.02 | 194 / 2642 | 2% | 0.16 | 15 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.16 | 1 / 45 |
| spleen | 0% | 0.47 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015881 | Biological process | creatine transmembrane transport |
| GO_0046449 | Biological process | creatinine metabolic process |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0005308 | Molecular function | creatine transmembrane transporter activity |
| GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
| GO_0015292 | Molecular function | uniporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC16A12 |
| Protein name | Solute carrier family 16 member 12 Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) |
| Synonyms | MCT12 |
| Description | FUNCTION: Functions as a transporter for creatine and as well for its precursor guanidinoacetate. Transport of creatine and GAA is independent of resting membrane potential and extracellular Na(+), Cl(-), or pH. Contributes to the process of creatine biosynthesis and distribution. . |
| Accessions | ENST00000371790.5 E9PPP4 Q6ZSM3 ENST00000475682.1 |
